A recent study published in Canadian Journal of Health Technologies examined the effectiveness of using metered-dose inhalers (MDIs) for medical cannabis and the evidence based guidelines for MDI use.

Syqe Medical, a pharma-tech company, announced Wednesday that it has obtained Health Canada's approval for its metered-dose medical cannabis inhaler. The inhaler releases predictable, controlled and ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

NEW ORLEANS, La - A company under the license of Southern University today announced an exclusive partnership to produce an inhalable medical cannabis formulation to benefit Louisiana Veterans ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

RYAH Medtech, Inc. subsidiary of RYAH Group, Inc. RYAH has received a Health Canada medical device license for its proprietary internet of things powered medical cannabis inhaler, proprietary ...

CoheroHealth, a New York City-based startup working on medication adherence tracking for asthma inhalers, is launching a small pilot with Mount Sinai Medical Center. The company will test its platform ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...